>
pdufa.bio

Litifilimab

Updated ยทnext FDA decision on the calendar

Litifilimab is a Biogen Inc. program. Its next catalyst is a Readout in Oct 2026. Every date links its source.

BIIB catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Biogen Inc. (BIIB). We track 2 catalyst events for this program: 1 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Sep 2026BIIBReadout · Oct 2026BIIB

Questions

When is Litifilimab's next FDA decision or readout?

The next tracked catalyst for Litifilimab is a Readout in Oct 2026.

What happened at Litifilimab's most recent FDA decision?

No FDA decision for Litifilimab is in our archive yet.

Who makes Litifilimab?

Biogen Inc. (BIIB).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.